US$ 26.62
is retatrutide fda approved yet Weight Loss Results:Trial Data and Status Demand for Unapproved Weight-Loss Drug
Description
Botulinum toxin for the treatment of gastroparesis: a preliminary report

Even in patients NOT taking GLP-1s, we see that slow motility can lead to dysbiosis (imbalance of harmful to beneficial bacteria) or SIBO (small intestinal bacterial overgrowth)
And if you get a positive pregnancy test by surprise, take a deep breath and call your ob-gyn
Lilly can try to sue companies that continue, but it hasn't had much luck in the past